Home/Filings/4/0001600132-18-000025
4//SEC Filing

Fernandes Peter 4

Accession 0001600132-18-000025

CIK 0001600132other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:56 PM ET

Size

6.8 KB

Accession

0001600132-18-000025

Insider Transaction Report

Form 4
Period: 2018-01-12
Fernandes Peter
Chief Regulatory Officer
Transactions
  • Award

    Common Stock

    2018-01-12+31,527113,980 total
  • Award

    Stock Option (right to buy)

    2018-01-12+100,000100,000 total
    Exercise: $2.03Exp: 2028-01-12Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant.

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001642618

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:56 PM ET
Size
6.8 KB